NCT05808530Completed
Cognitive Stimulation Therapy
The Effect of Cognitive Stimulation Therapy on Apathy, Loneliness, Anxiety and Activities of Daily Living in Elderly Individuals Diagnosed With Alzheimer's
Source: ClinicalTrials.gov · Last updated 15 Mar 2024
Brief summary (registry, in English)
The concept of cognitive stimulation in AD is one of the most popular approaches. Cognitive Stimulation Therapy (CST) is stated to be evidence-based best practice with robust clinical trials, administered according to specific guidelines for individuals with mild to moderate dementia. In this study, it was aimed to investigate the effects of CST application on the levels of apathy, loneliness, anxiety and daily living activities in elderly individuals with Alzheimer's disease. This research was planned in an experimental research design with a single center and pretest posttest control group. The research was planned to be carried out between January 2023 and June 202 at the Moral House of Gaziantep Metropolitan Municipality, Department of Disabled and Health Services. Introductory Information Form, Standardized Mini-Mental Test, Geriatric Anxiety Scale, Apathy Rating Scale, Loneliness Scale and Functional Disability in Dementia Scale will be used in the research. CST will be administered by a researcher trained in therapy, 2 days a week, for a total of 14 sessions of 45-50 minutes. There will be a pre-test before the application, an intermediate test right after the application, and a post-test three months later. Research data will be evaluated in SPSS 25.0 New York package program.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 56 (actual)
- First submitted
- 14 Jan 2023
- Start date
- May 2023
- Primary completion date
- Oct 2023
- Lead sponsor
- Hasan Kalyoncu University
- Diseases
- Alzheimer disease
- NCT number
- NCT05808530
What you commit to
- Study type: Interventional
- Participants enrolled: 56
- From May 2023 to the primary completion date, Oct 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Not meeting any of the research inclusion criteria,
- Have not attended at least two sessions of the CST program,
- Patients who refuse/want to leave the CST program will be excluded from the study by the investigator.
Who the study is looking for
- 60 years or older,
- Having a mild Alzheimer's diagnosis and a Standardized Mini Mental Test score in the range of 18-23,
- Able to speak and understand Turkish,
- Hearing, understanding, seeing and speaking problems,
- Having no physical illness or disability to participate in group work,
- Have not participated in the CST program before, Individuals who volunteer to participate in the research will be included in the study.
Age in the registry: 60 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hasan Kalyoncu University Coordinator of this site? Confirm its status | Gaziantep | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.